QQ客服 官方微博 反馈留言

	A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
	Wang, Yan; Yu, Yi-yi; Li, Wei; Feng, Yi; Hou, Jun; Ji, Yuan; Sun, Yi-hong; Shen, Kun-tang; Shen, Zhen-bin; Qin, Xin-yu
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2014
卷号	73期号:6
关键词	Gastric cancer Para-aortic lymph node Chemotherapy
ISSN号	0344-5704
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4888788
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Yan,Yu, Yi-yi,Li, Wei,et al. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2014,73(6).
APA	Wang, Yan.,Yu, Yi-yi.,Li, Wei.,Feng, Yi.,Hou, Jun.,...&Liu, Tian-shu.(2014).A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.CANCER CHEMOTHERAPY AND PHARMACOLOGY,73(6).
MLA	Wang, Yan,et al."A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis".CANCER CHEMOTHERAPY AND PHARMACOLOGY 73.6(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。